ANTIBODY FORMULATIONS

PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides antibody formulations, including monoclonal antibodies formulated in a histidine-acetate buffer, and a formulation comprising an antibody that bi...

Full description

Saved in:
Bibliographic Details
Main Authors ANDYA JAMES D, LIU JUN, SHEN YE, GWEE SHIANG C
Format Patent
LanguageEnglish
Published 04.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides antibody formulations, including monoclonal antibodies formulated in a histidine-acetate buffer, and a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).
AbstractList PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides antibody formulations, including monoclonal antibodies formulated in a histidine-acetate buffer, and a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).
Author LIU JUN
GWEE SHIANG C
SHEN YE
ANDYA JAMES D
Author_xml – fullname: ANDYA JAMES D
– fullname: LIU JUN
– fullname: SHEN YE
– fullname: GWEE SHIANG C
BookMark eNrjYmDJy89L5WQQdfQL8XTyd4lUcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGJoamliZmlo7GRCkCALb0IV0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID JP2014159469A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2014159469A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:27:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2014159469A3
Notes Application Number: JP20140097390
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140904&DB=EPODOC&CC=JP&NR=2014159469A
ParticipantIDs epo_espacenet_JP2014159469A
PublicationCentury 2000
PublicationDate 20140904
PublicationDateYYYYMMDD 2014-09-04
PublicationDate_xml – month: 09
  year: 2014
  text: 20140904
  day: 04
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies GENENTECH INC
RelatedCompanies_xml – name: GENENTECH INC
Score 2.9467661
Snippet PROBLEM TO BE SOLVED: To provide a formulation that retards degradation of an antibody product in the formulation.SOLUTION: The present invention provides...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ANTIBODY FORMULATIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140904&DB=EPODOC&locale=&CC=JP&NR=2014159469A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUs1SjY3TDHUtUhMNNU1SUlK1bUwSTbTBU25JZoYp1gYmoM2OPv6mXmEmnhFmEYwMWTD9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGHR6EzDSXZxsXQP8Xfyd1Zydbb0C1PyCwHLAmhvYGXRkZmAFtqPNwb22MCfQtpQC5DrFTZCBLQBoXF6JEANTap4wA6cz7Oo1YQYOX-iMN5AJzXzFIgyijn4hnk7-LpEKwJ6bb6gPZAewKIOSm2uIs4cu0Px4uG_ivQKQ3GIsxsAC7OanSjAopAArXoNUc1NgFZtoYpCclARseSVZGKUYGqVZpgGxJIM0HoOk8MpKM3CBeOC1USYyDCwlRaWpssDKtCRJDhwIAOLVdLM
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUs1SjY3TDHUtUhMNNU1SUlK1bUwSTbTBU25JZoYp1gYmoM2OPv6mXmEmnhFmEYwMWTD9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGHR6EzDSXZxsXQP8Xfyd1Zydbb0C1PyCwHLAmhvYGXRkZmAFtrEtwH2lMCfQtpQC5DrFTZCBLQBoXF6JEANTap4wA6cz7Oo1YQYOX-iMN5AJzXzFIgyijn4hnk7-LpEKwJ6bb6gPZAewKIOSm2uIs4cu0Px4uG_ivQKQ3GIsxsAC7OanSjAopAArXoNUc1NgFZtoYpCclARseSVZGKUYGqVZpgGxJIM0HoOk8MrKM3B6hPj6xPt4-nlLM3CBZMDrpExkGFhKikpTZYEVa0mSHDhAAILXd6M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTIBODY+FORMULATIONS&rft.inventor=ANDYA+JAMES+D&rft.inventor=LIU+JUN&rft.inventor=SHEN+YE&rft.inventor=GWEE+SHIANG+C&rft.date=2014-09-04&rft.externalDBID=A&rft.externalDocID=JP2014159469A